Cost considerations in determining the affordability of adjuvant trastuzumab in breast cancer

• Waldemar Szpak,
• Raymond P Abratt

Affiliations

Waldemar Szpak

Rainbow Oncology, Amanzimtoti, South Africa

Raymond P Abratt

Independent Clinical Oncology Network Emeritus Professor of Radiation Oncology, University of Cape Town, South Africa